
News|Articles|October 1, 2006
High-dose statin therapy displays benefit in preventing cardiovascular events compared with standard doses
Intensive lipid lowering with high-dose 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) provides a significant benefit over standard-dose statin therapy in preventing nonfatal cardiovascular outcomes and also may reduce the incidence of cardiovascular death, according to results of a meta-analysis published in the Journal of the American College of Cardiology.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Icotrokinra Demonstrates High Clearance Rates in Plaque Psoriasis | Fall Clinical Derm 2025
2
1 in 10 U.S. Adults Have Physician-Diagnosed Chronic Hand Eczema, Study Shows | Fall Clinical Derm 2025
3
Digital Tool Helps More Adults Get Screened for Lung Cancer
4
ICER Analysis Finds Net Prices of New Drugs Rose 51% Over Three Years
5



















































